All filters
Slidesets
(Abstract) The prevalence of HBV, HCV and HIV infection in Romania - a nationwide screening program for surveillance of viral infections | O. Sandulescu
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
IVDU | Pavel Khaykin, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Update of new drugs | Cihan Yurdaydin, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Drug-Drug Interactions: considerations | Anca Streinu-Cercel, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Tackling the issues: Caring for HIV-positive women today | Anna Maria Geretti, MD, PhD, FRCPath
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
HIV and Pediatrics in Central Europe | Mariana Mărdărescu, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
(Abstract) HCV reinfection in HCV/HIV coinfected patients treated for VHC in AIDS Center Prague | V. Aster
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
(Abstract) Expression of NS4 HCV in liver cells of HIV/HCV co-infected patients | N. Matsiyeuskaya
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
(Abstract) Chronic Hepatitis C Treatment among HIV/HCV co-infected PWID in Ukraine: communitysupported treatment model experience | T. Barnard
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
(Abstract) Quality of life in patients with HCV/ HIV co-infection | O. Shevchenko
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
(Abstract) Predictors of HIV co-infection in HCV infected patients in Serbia | M. Stanojevic
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Local situation in Romania | Oana Săndulescu, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
(Abstract) Cost-efficiency versus Potency | Anca Streinu-Cercel, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Local situation in Ukraine | Pavlo Skala
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Local situation in the Baltic countries | Saulius Caplinskas, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Local situation in Slovenia and the Balcan countries | Mojca Maticic, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Local situation in Poland | Miłosz Parczewski, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Local situation in Czech and Slovak Republics | Viktor Aster, MD, PHD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Local situation in Georgia | Akaki Abutidze, MD, MPH, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Pharmacokinetic, Safety and Efficacy of Darunavir/Ritonavir in HIV+ Pregnant Women - Dr. Minh Patrick Le
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Slidesets
Raltegravir (RAL) Pharmacokinetics (PK) and Safety in HIV-1 Exposed Neonates at High Risk of Infection (IMPAACT P1110) - Dr. Diana Clarke
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Slidesets
Timing of the postpartum curve in pharmacokinetic studies in pregnancy should not be too early - Angela Colbers, PhD
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016